Browse Technologies

Displaying 21 - 22 of 22

Treating Glioblastoma by a Combination Therapy of Gamma-secretase inhibitors and Farnesyltransferase Inhibitors

Scientists at Vanderbilt have developed a novel therapy for gliobastoma multiform that results in minimal recurrence of the tumor. The therapy combines two inhibitors that effectively compromise tumor cell growth and survival. The therapy can be followed by radiation, a common treatment for cancer cells.

Licensing Contact

Karen Rufus



Jialiang Wang

Inhibitors of Inward-Rectifying Potassium Channels (Insecticide)

This research targets IRK.

Licensing Contact

Tom Utley